• Why Choose Us

    Top-Rated Care for Pediatric Cancer and Blood Disorders

    Dana-Farber/Boston Children’s Cancer and Blood Disorders Center offers the combined expertise of both a world class cancer center and an internationally renowned children’s hospital. Neighboring institutes connected by pedestrian bridges, Dana-Farber Cancer Institute and Boston Children’s Hospital work together to offer seamless, integrated care for children with all types of cancer and blood disorders – including the rarest and most complex cases. Through our joint partnership, Dana-Farber/Boston Children’s offers more specialists, more treatment options, and more clinical trials than almost any other pediatric center treating cancer and blood disorders in the world.

    Learn more

    • Expertise: We provide specialized in-depth expertise in treating children with cancer and blood disorders.
    • Innovative approaches: We offer a range of innovative approaches to the treatment of pediatric cancer and blood disorders.
    • Survivorship: Caring for children with cancer and blood disorders doesn’t end after treatment. Our survivorship programs are the nation’s models for cancer survivorship care.
    • Global health: Our Global Health Initiative is a leader in developing outreach initiatives that improve outcomes and survival rates for children with cancer and blood disorders worldwide.
    • Our leadership: Our leadership team members are internationally recognized researchers and physicians.
    • History and milestones: Dana-Farber/Boston Children's has a long history as a world leader in the research and treatment of cancer and blood disorders.
  • Contact Us

    Our specialized new patient coordinators can answer your questions about treatment options and becoming a patient.
  • Top Ranked for Cancer Care

    U.S. News Best Children's Hospitals logoWorld class cancer care at the #1 children's hospital

  • Gene Therapy Gives Agustin a Normal Life

    gene therapy storyBorn with “bubble boy” disease, Agustin now has a normal life after gene therapy.

  • Follow Us!

    Twitter Logo Our Twitter handle is:
  • Clinical Trials for Relapsed Cancer

    acct programFor patients with relapsed, refractory, or recurrent cancer, early phase clinical trials may be a treatment option.